Because food remains in the stomach longer, patients often experience prolonged fullness, reduced appetite, and altered tolerance to certain foods
Rated 5 out of 5 Kayleigh M
Loose skin risk correlates with amount of weight lost, speed of loss, age, and individual skin elasticity rather than the specific method of weight loss
Among 169,649 patients with MASLD, GLP-1 receptor agonist initiation was linked to significantly lower probability of incident cirrhosis [adjusted hazard ratio (aHR): 0.86, 95%CI: 0.80-0.93], hepatic decompensation (aHR: 0.77, 95%CI: 0.65-0.90), and hepatocellular carcinoma (HCC) (aHR: 0.79, 95%CI: 0.68-0.92) over a median follow-up of 3.5 years compared to non-users